Evidence map›Paper›PMID 33294202›Full record

ArticleCanadian journal of kidney health and disease2020

Management of Patients With Glomerulonephritis During the COVID-19 Pandemic: Recommendations From the Canadian Society of Nephrology COVID-19 Rapid Response Team.

Sarah M Moran, Sean Barbour, Christine Dipchand, Jocelyn S Garland, Michelle Hladunewich, Arenn Jauhal, Joanne E Kappel, Adeera Levin, Sanjay Pandeya, Heather N Reich and 5 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Canadian journal of kidney health and disease, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.1field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 9 institutions in 1 country.

Sarah M MoranDivision of Nephrology, Queen's University, Kingston, ON, Canada.ORCID https://orcid.org/0000-0001-9377-4133
Sean BarbourDivision of Nephrology, The University of British Columbia, Vancouver, BC, Canada.
Christine DipchandDivision of Nephrology, Dalhousie University, Halifax, NS, Canada.
Jocelyn S GarlandDivision of Nephrology, Queen's University, Kingston, ON, Canada.
Michelle HladunewichDivision of Nephrology, University of Toronto, ON, Canada.ORCID https://orcid.org/0000-0001-9227-4292
Arenn JauhalOntario Renal Network, Toronto, ON, Canada.
Joanne E KappelDivision of Nephrology, Department of Medicine, University of Saskatchewan, Saskatoon, Canada.
Adeera LevinDivision of Nephrology, The University of British Columbia, Vancouver, BC, Canada.
Sanjay PandeyaHalton Healthcare, Oakville, ON, Canada.
Heather N ReichDivision of Nephrology, Dalhousie University, Halifax, NS, Canada.
Susan ThanabalasingamDivision of Nephrology, Queen's University, Kingston, ON, Canada.ORCID https://orcid.org/0000-0002-8948-1730
Dorothy ThomasUniversity of Calgary, AB, Canada.
Jeffrey C MaSaskatchewan Health Authority, Saskatoon, Canada.
Christine WhiteDivision of Nephrology, Queen's University, Kingston, ON, Canada.
CSN COVID-19 Rapid Response Team
Queen's University · CAUniversity of British Columbia · CAUniversity of Saskatchewan · CADalhousie University · CAHalTech · CAOntario Stroke Network · CASaskatchewan Health Authority · CAUniversity of Calgary · CAUniversity of Toronto · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purpose of programThis article will provide guidance on how to best manage patients with glomerulonephritis (GN) during the COVID-19 pandemic. SOURCES OF INFORMATION: We reviewed relevant published literature, program-specific documents, and guidance documents from international societies. An informal survey of Canadian nephrologists was conducted to identify practice patterns and expert opinions. We hosted a national webinar with invited input and feedback after webinar.

methodsThe Canadian Society of Nephrology (CSN) Board of Directors invited physicians with expertise in GN to contribute. Specific COVID-19-related themes in GN were identified, and consensus-based recommendations were made by this group of nephrologists. The recommendations received further peer input and review by Canadian nephrologists via a CSN-sponsored webinar. This was attended by 150 kidney health care professionals. The final consensus recommendations also incorporated review by Editors of the KEY

findingsWe identified 9 areas of GN management that may be affected by the COVID-19 pandemic: (1) clinic visit scheduling, (2) clinic visit type, (3) provision of multidisciplinary care, (4) blood and urine testing, (5) home-based monitoring essentials, (6) immunosuppression, (7) other medications, (8) patient education and support, and (9) employment. LIMITATIONS: These recommendations are expert opinion, and are subject to the biases associated with this level of evidence. To expedite the publication of this work, a parallel review process was created that may not be as robust as standard arm's length peer review processes. IMPLICATIONS: These recommendations are intended to provide optimal care during the COVID-19 pandemic. Our recommendations may change based on the evolving evidence.

Indexed as

chronic kidney diseaseglomerulonephritisinfectious diseasesinflammation

Identifiers

PMID33294202
PMCPMC7705766
OpenAlexW3109589904

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.